Nucleus RadioPharma

Nucleus RadioPharma is a pioneering contract development and manufacturing organization (CDMO) dedicated to the radiopharmaceutical industry. Founded by the Mayo Clinic and venture capital firm Eclipse, the company provides a fully integrated platform to manage the complex development, manufacturing, and supply chain logistics required for targeted radiotherapies. Led by CEO Dr. Stephen Hahn, former FDA Commissioner, Nucleus is addressing critical industry bottlenecks by establishing a nationwide network of advanced manufacturing facilities to ensure the reliable delivery of precision cancer treatments. The company's end-to-end model includes isotope procurement, formulation development, and GMP-compliant production to accelerate the clinical and commercial path for its partners.